Navigation mit Access Keys

Search


First Innosuisse project at the Biozentrum

The project entitled «Development of a lead compound for specific mTORC1 inhibition» is the first Innosuisse funded project at the Biozentrum. Replacing the former Swiss Commission for Technology and Innovation (CTI), the…


Alex Schier awarded distinction of AAAS Fellow

The cell and developmental biologist Prof. Alex Schier, from the Biozentrum of the University of Basel, has been recognized for his work on embryonic development, in particular, for establishing and applying genetic and…


Nobel laureate Christiane Nüsslein-Volhard at the Biozentrum

The kick off for this year’s “Biozentrum Lectures” series will be presented by the distinguished developmental biologist and Nobel laureate Prof. Christiane Nüsslein-Volhard from the Max Planck Institute for Developmental…


ERC Consolidator Grants for two Biozentrum researchers

With the Consolidator Grants, the ERC supports highly qualified scientists with several years of research experience and a promising scientific track-record. Today, the ERC announced the 349 laureates of the 2025 ERC…


New Assistant Professor appointed to the Biozentrum

On Monday, August 26, 2024, the University Council appointed Claudia Keller Valsecchi as the new Assistant Professor of Molecular Biology with Tenure Track at the Biozentrum. Claudia Keller Valsecchi, currently research…


Torsten Schwede appointed as new President of the SNSF Research Council

Torsten Schwede, a current member of the President’s Board of the University, is set to lead one of Switzerland's most important academic bodies. The chemist heads a research group for structural bioinformatics at the…


Marek Basler newly elected EMBO member

On July 4, 2023, EMBO announced the newly elected members, including Prof. Marek Basler from the Biozentrum of the University of Basel. Including Marek Basler, a total of 33 scientists have been recognized for their…


Awards for Biozentrum junior researchers

Young scientists make a major contribution to research: They are the foundation, innovative force and future of universities and research institutions. Almost half of the staff at the Biozentrum are PhD students and…


Aukera Therapeutics Comes Out of Stealth and Enters Preclinical Efficacy Studies

Aukera Therapeutics was founded in 2021 at the Biozentrum, University of Basel. Built on pioneering academic research and deep mTOR expertise, the company is now officially emerging from stealth as it advances its lead…


Médéric Diard receives prestigious ERC Consolidator Grant

The European Research Council (ERC) today announced the recipients of this year’s ERC Consolidator Grants: A total of 327 applicants from all over Europe have been awarded this prestigious grant including Prof. Médéric Diard…